Is the mortality rate for septic shock really decreasing?
dc.contributor.author | Christaki, Eirini | en |
dc.contributor.author | Opal, Steven M. | en |
dc.creator | Christaki, Eirini | en |
dc.creator | Opal, Steven M. | en |
dc.date.accessioned | 2018-06-22T09:52:48Z | |
dc.date.available | 2018-06-22T09:52:48Z | |
dc.date.issued | 2008 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/41514 | |
dc.description.abstract | Survival rates for patients in septic shock have gradually improved in critical care units worldwide over the last 25 years. Further improvement will be predicated on the discovery of new therapies to disrupt the underlying pathophysiology of sepsis and the development of improved rapid, diagnostic testing and immune monitoring of individual patients. © 2008 Wolters Kluwer Health|Lippincott Williams & Wilkins. | en |
dc.language.iso | eng | en |
dc.source | Current opinion in critical care | en |
dc.subject | United states | en |
dc.subject | Human | en |
dc.subject | Patient care | en |
dc.subject | Humans | en |
dc.subject | Cancer patient | en |
dc.subject | Quantitative analysis | en |
dc.subject | Drug efficacy | en |
dc.subject | Neutropenia | en |
dc.subject | Granulocyte colony stimulating factor | en |
dc.subject | Survival | en |
dc.subject | Survival rate | en |
dc.subject | Treatment outcome | en |
dc.subject | Review | en |
dc.subject | Outcome assessment | en |
dc.subject | Antibiotic agent | en |
dc.subject | Human immunodeficiency virus infection | en |
dc.subject | Immunosuppressive agent | en |
dc.subject | Mortality | en |
dc.subject | Immunoglobulin | en |
dc.subject | Recombinant erythropoietin | en |
dc.subject | Hypotension | en |
dc.subject | High risk population | en |
dc.subject | Disease severity | en |
dc.subject | Erythrocyte transfusion | en |
dc.subject | Thrombocyte transfusion | en |
dc.subject | Patient monitoring | en |
dc.subject | Adrenalin | en |
dc.subject | Pathophysiology | en |
dc.subject | Kidney function | en |
dc.subject | Clinical protocol | en |
dc.subject | Infection risk | en |
dc.subject | Artificial ventilation | en |
dc.subject | Intensive care unit | en |
dc.subject | Acute kidney failure | en |
dc.subject | Renal replacement therapy | en |
dc.subject | Respiratory failure | en |
dc.subject | Antibiotic therapy | en |
dc.subject | Sepsis | en |
dc.subject | Septic shock | en |
dc.subject | Bacteremia | en |
dc.subject | Antibiotic prophylaxis | en |
dc.subject | Antifungal agent | en |
dc.subject | Antiinfective agent | en |
dc.subject | Burn | en |
dc.subject | Candidiasis | en |
dc.subject | Catecholamine derivative | en |
dc.subject | Catheter removal | en |
dc.subject | Cause of death | en |
dc.subject | Child health care | en |
dc.subject | Critically ill patient | en |
dc.subject | Dopamine | en |
dc.subject | Drotrecogin | en |
dc.subject | Epidemiologic studies | en |
dc.subject | Extracorporeal oxygenation | en |
dc.subject | Fluid resuscitation | en |
dc.subject | Fungemia | en |
dc.subject | Geriatric care | en |
dc.subject | Glucose | en |
dc.subject | Glucose blood level | en |
dc.subject | Glycemic control | en |
dc.subject | Hematopoietic stem cell transplantation | en |
dc.subject | Hemodialysis | en |
dc.subject | Hemodynamics | en |
dc.subject | Hemofiltration | en |
dc.subject | Highly active antiretroviral therapy | en |
dc.subject | Hospital mortality | en |
dc.subject | Human immunodeficiency virus antibody | en |
dc.subject | Hydrocortisone | en |
dc.subject | Immune system | en |
dc.subject | Infection prevention | en |
dc.subject | Injury | en |
dc.subject | Inotropic agent | en |
dc.subject | Insulin | en |
dc.subject | Insulin treatment | en |
dc.subject | Intravenous administration | en |
dc.subject | Noradrenalin | en |
dc.subject | Nutritional support | en |
dc.subject | Opportunistic infection | en |
dc.subject | Resuscitation | en |
dc.subject | Septic | en |
dc.subject | Shock | en |
dc.subject | Survival rates | en |
dc.subject | Tissue oxygenation | en |
dc.subject | Vasopressin | en |
dc.title | Is the mortality rate for septic shock really decreasing? | en |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | 10.1097/MCC.0b013e32830f1e25 | |
dc.description.volume | 14 | |
dc.description.issue | 5 | |
dc.description.startingpage | 580 | |
dc.description.endingpage | 586 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Christaki, Eirini [0000-0002-8152-6367] | |
dc.gnosis.orcid | 0000-0002-8152-6367 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |